Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Patrys Limited ( (AU:PAB) ) just unveiled an update.
Patrys Limited has applied to the ASX for quotation of 466,666 new ordinary fully paid shares, expanding the number of securities on issue under its ticker PAB. The additional shares result from the exercise or conversion of existing options or other convertible securities, modestly increasing the company’s equity base and potentially enhancing its trading liquidity for investors.
The new securities are scheduled to be quoted with an issue date of 10 February 2026, following the company’s formal submission of an Appendix 2A application. While the issuance is relatively small, it reflects ongoing capital management activity and maintains the company’s compliance with ASX listing requirements for newly created shares.
More about Patrys Limited
Patrys Limited is an Australian biotechnology company listed on the ASX under the code PAB. The company operates in the life sciences sector, focusing on the development of therapeutic products, and raises capital through the issuance and quotation of ordinary fully paid shares on the Australian market.
Average Trading Volume: 548,437
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$18.19M
See more data about PAB stock on TipRanks’ Stock Analysis page.